Prostate News and Research

RSS

New research suggests power of zebrafish as tool for cancer drug discovery

The lab of Leonard Zon, MD, at Boston Children's Hospital has long been interested in making blood stem cells in quantity for therapeutic purposes.

24 Sep 2018

Public awareness of urological conditions found to be alarmingly low across Europe

Public awareness of urological conditions is alarmingly low throughout Europe. Results of a new international survey of more than 2,500 responders from 5 countries show that women know more about men's health issues than men do, men have poor knowledge of key urological symptoms and don't take early signs of potentially life-threatening urological conditions seriously.

24 Sep 2018

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

Ipsen announced today that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, provided a positive opinion for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma in adults who have been previously treated with sorafenib.

21 Sep 2018

Study: Annual wellness visits improve delivery of preventive services in elderly population

new Harvey L. Neiman Health Policy Institute study assesses the effect of receiving an Annual Wellness Visit between 2011 and 2013 on the annual rate of eight preventive services recommended for the Medicare population following the AWV.

21 Sep 2018

UK and European research collaborations receive vote of confidence by three major cancer charities

UK and European research collaborations in cancer research have received a vote of confidence by three major cancer charities, with an announcement today of approximately £30 million into six international projects.

20 Sep 2018

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

An analysis of the NRG Oncology clinical trial NRG-GY003 suggests that adding ipilimumab, a monoclonal antibody that targets the protein receptor CTLA-4, to a regimen with the checkpoint inhibitor nivolumab could improve the proportion with tumor response and progression-free survival hazard rates for women with recurrent epithelial ovarian cancer.

19 Sep 2018

Study: Consumption of foods with lower nutritional quality related to increased cancer risk

The consumption of foods with higher scores on the British Food Standards Agency nutrient profiling system (FSAm-NPS), reflecting a lower nutritional quality, is associated with an increased risk of developing cancer, according to a study published this week in PLOS Medicine.

19 Sep 2018

Innovative procedure could provide breakthrough in treating early-stage lung cancer

A new minimally invasive surgery could provide a breakthrough in treating early-stage lung cancer, based on a review of some of the first patients to receive the procedure.

19 Sep 2018

US Department of Defense offers three-year grant for UIC study on prostate cancer

A new three-year grant totaling nearly $1 million from the U.S. Department of Defense will fund University of Illinois at Chicago research on the gene SELENOF and its role in the development of prostate cancer among black men.

14 Sep 2018

Medicare incurs more than $1.2 billion over prostate cancer care in older men

Researchers from the University of North Carolina Lineberger Comprehensive Cancer Center estimate that screening for and treating prostate cancer in men aged 70 years or older, which is not recommended by national guidelines, cost Medicare more than $1.2 billion over a three year period for each group of men diagnosed in the United States each year.

14 Sep 2018

Annual survey highlights poor awareness of sepsis in the US

A new survey has revealed that, although awareness of sepsis is increasing in the US, there are still very few people who are able to recognize the symptoms.

13 Sep 2018

Cancer to kill nearly 10 million this year says WHO report

According to a report released by the World Health Organization’s cancer research agency this week, 9.6 million people would lose their lives to cancer this year. This translates as one in eight of all deaths and one in eleven of all deaths among men and women respectively says the agency.

13 Sep 2018

MilliDrop awarded €1.9 million to accelerate development of blood infection diagnosis system

MilliDrop, which designs and develops cell culture solutions based on millifluidics technology for bacteriological research and diagnosis purposes, announces it has been awarded €1.9 million in non-dilutive financing from Bpifrance to accelerate the development of its blood infection diagnosis system for sepsis.

12 Sep 2018

Researchers develop technology to help deconstruct surgeons' robotic surgery skills

Researchers from the Keck School of Medicine of USC are looking to technology to help deconstruct expert surgeons' robotic surgery skills so they can create an objective, standardized way to train the next generation of surgeons.

11 Sep 2018

Synergism between HOXB13 and CIP2A genes predisposes men to get prostate cancer

A research team at the University of Turku in Finland discovered a link between the interplay of certain simultaneously occurring genetic changes in the HOXB13 and CIP2A genes, aggressiveness of prostate cancer, high risk of developing the disease, and poorer survival rates of patients.

11 Sep 2018

Major pitfall identified in popular prostate cancer PET imaging method

Prostate-specific membrane antigen positron emission tomography imaging has become a popular method for determining the stage of a patient's prostate cancer.

7 Sep 2018

Research team identifies new therapeutic target for castration-resistant prostate cancer

A collaborative research team has linked the development of castration-resistant prostate cancer and resistance to treatment to a lack of androgen receptor expression in prostate cancer cells, identifying a new therapeutic target for one of the deadliest forms of cancer among men.

7 Sep 2018

Prostate News and Research

New research suggests power of zebrafish as tool for cancer drug discovery

Public awareness of urological conditions found to be alarmingly low across Europe

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

Study: Annual wellness visits improve delivery of preventive services in elderly population

UK and European research collaborations receive vote of confidence by three major cancer charities

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

Study: Consumption of foods with lower nutritional quality related to increased cancer risk

Innovative procedure could provide breakthrough in treating early-stage lung cancer

US Department of Defense offers three-year grant for UIC study on prostate cancer

Medicare incurs more than $1.2 billion over prostate cancer care in older men

Annual survey highlights poor awareness of sepsis in the US

Cancer to kill nearly 10 million this year says WHO report

MilliDrop awarded €1.9 million to accelerate development of blood infection diagnosis system

Researchers develop technology to help deconstruct surgeons' robotic surgery skills

Synergism between HOXB13 and CIP2A genes predisposes men to get prostate cancer

Major pitfall identified in popular prostate cancer PET imaging method

Research team identifies new therapeutic target for castration-resistant prostate cancer

Link discovered between tumor genome changes and mortality risk across cancer types

Cancer, schmancer. In California, coffee is king

Urological problems in men linked to depression and sleep disorders

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News